Enteric Coating
About Enteric Coating
Enteric coating is a pharmaceutical technology used to protect orally administered drugs from the acidic environment of the stomach, ensuring release in the intestine. It involves polymers that resist stomach dissolution and break down at higher pH, improving drug stability and tolerability.
Trend Decomposition
Trigger: Ongoing demand for gastro resistant dosage forms and improved patient adherence driving scale up of enteric coating polymers and processes.
Behavior change: Pharmaceutical developers increasingly select and optimize enteric coatings early in formulation design to control release profiles and minimize GI side effects.
Enabler: Advanced polymer technologies (eudragit like polymers), predictive dissolution testing, and enhanced coating application technologies reduce development time and variability.
Constraint removed: Improved processing controls and quality by design reduce batch to batch variability in coating performance.
PESTLE Analysis
Political: Regulatory emphasis on consistent bioavailability and patient safety incentivizes robust enteric coating quality.
Economic: Higher value, gastro resistant formulations command premium pricing and drive investment in coating research and manufacturing capacity.
Social: Growing prevalence of chronic GI conditions and demand for convenient, tolerable oral dosage forms increases acceptance of coated products.
Technological: Innovations in polymer chemistry, film coating hardware, and in vitro in vivo correlation accelerate development of enteric coated products.
Legal: Regulatory expectations for robust dissolution profiles and thorough stability data pressure developers to maintain high quality standards.
Environmental: Solvent reduction and more efficient coating processes lessen environmental footprint of manufacturing
Jobs to be done framework
What problem does this trend help solve?
It solves the need to deliver drugs to the intestinal region while protecting them from stomach acid and reducing gastric irritation.What workaround existed before?
Non enteric formulations or immediate release coatings that risk mucosal irritation or poor bioavailability.What outcome matters most?
Consistent, predictable release timing, high bioavailability, and improved patient tolerability at acceptable cost.Consumer Trend canvas
Basic Need: Safe and effective oral drug delivery with controlled release characteristics.
Drivers of Change: Demand for patient friendly regimens, better therapeutic outcomes, and regulatory focus on quality.
Emerging Consumer Needs: Fewer GI side effects and more reliable dosing in diverse patient populations.
New Consumer Expectations: Transparent performance data and consistent manufacturing quality across batches.
Inspirations / Signals: Success stories of gastro resistant formulations and new polymer platforms in late stage development.
Innovations Emerging: Novel enteric polymers, multi layer coating strategies, and predictive dissolution models.
Companies to watch
- Evonik Industries - Leading supplier of enteric polymers such as Eudragit for controlled release coatings.
- BASF - Provides polymer and excipient solutions including enteric coating components used in pharmaceutical formulations.
- Colorcon - Provider of film coatings and global coating technologies for tablets and capsules.
- Dow Inc. - Industrial polymers and excipients that support film coating formulations and manufacturing processes.
- Shin-Etsu Chemical - Supplier of pharmaceutical polymers and specialty materials used in coating technologies.
- Sekisui Chemical - Producer of pharmaceutical polymers and coating related materials used in enteric formulations.
- Lonza - Capsugel and related excipient solutions including coating technologies used with oral dosage forms.